Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Tenaya Therapeutics, Inc. (TNYA) had Free Cash Flow of $-91.53M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-111.13M |
|
-- |
|
-- |
|
$115.95M |
|
$-115.95M |
|
$4.82M |
|
$-111.13M |
|
$-111.13M |
|
$-111.13M |
|
$-111.13M |
|
$-111.13M |
|
$-111.13M |
|
$-115.95M |
|
$-107.66M |
|
84.82M |
|
84.82M |
|
$-1.31 |
|
$-1.31 |
|
| Balance Sheet Financials | |
$67.38M |
|
$35.86M |
|
$52.56M |
|
$119.94M |
|
$15.97M |
|
-- |
|
$11.11M |
|
$27.09M |
|
$92.85M |
|
$92.85M |
|
$92.85M |
|
86.54M |
|
| Cash Flow Statement Financials | |
$-90.50M |
|
$1.13M |
|
$47.75M |
|
$46.36M |
|
$4.74M |
|
$-41.62M |
|
$16.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-91.53M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-119.68% |
|
-119.68% |
|
-92.65% |
|
-119.68% |
|
$1.07 |
|
$-1.08 |
|
$-1.07 |
|